269 related articles for article (PubMed ID: 8701418)
41. Synthetic RGDS-containing peptides of von Willebrand factor inhibit platelet adhesion to collagen.
Fressinaud E; Girma JP; Sadler JE; Baumgartner HR; Meyer D
Thromb Haemost; 1990 Dec; 64(4):589-93. PubMed ID: 2084945
[TBL] [Abstract][Full Text] [Related]
42. Type I von Willebrand disease, subtype 'platelet low': decreased platelet adhesion can be explained by low synthesis of von Willebrand factor in endothelial cells.
Federici AB; de Groot PG; Moia M; Ijsseldijk MJ; Sixma JJ; Mannucci PM
Br J Haematol; 1993 Jan; 83(1):88-93. PubMed ID: 8435340
[TBL] [Abstract][Full Text] [Related]
43. Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding.
Huizinga EG; Martijn van der Plas R; Kroon J; Sixma JJ; Gros P
Structure; 1997 Sep; 5(9):1147-56. PubMed ID: 9331419
[TBL] [Abstract][Full Text] [Related]
44. Clumping factor A, von Willebrand factor-binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall.
Claes J; Liesenborghs L; Peetermans M; Veloso TR; Missiakas D; Schneewind O; Mancini S; Entenza JM; Hoylaerts MF; Heying R; Verhamme P; Vanassche T
J Thromb Haemost; 2017 May; 15(5):1009-1019. PubMed ID: 28182324
[TBL] [Abstract][Full Text] [Related]
45. Effects of endothelin-1 and phenylephrine on plasma levels of von Willebrand factor and protein S.
Leitner GC; Schmetterer L; Kapiotis S; Jilma B
Thromb Res; 2010 Jan; 125(1):e5-8. PubMed ID: 19729191
[TBL] [Abstract][Full Text] [Related]
46. In vitro phosphorylation of von Willebrand factor by FAM20c enhances its ability to support platelet adhesion.
Da Q; Han H; Valladolid C; Fernández M; Khatlani T; Pradhan S; Nolasco J; Matsunami RK; Engler DA; Cruz MA; Vijayan KV
J Thromb Haemost; 2019 Jun; 17(6):866-877. PubMed ID: 30864273
[TBL] [Abstract][Full Text] [Related]
47. Loss of blood platelet adhesion after heating native and cultured human subendothelium to 100 degrees Celcius.
Borst C; Bos AN; Zwaginga JJ; Rienks R; de Groot PG; Sixma JJ
Cardiovasc Res; 1990 Aug; 24(8):665-8. PubMed ID: 2224934
[TBL] [Abstract][Full Text] [Related]
48. β-radiation reduces the reactivity of extracellular matrix proteins in intravascular brachytherapy (IVBT), resulting in decreased platelet adhesion.
Wu YP; Stella PR; Chen SF; Wang YT; Wang JY; Moerland MA; Pan SD; Zhang B; Li GY; Doevendans PA; de Groot PG
Int J Cardiol; 2012 May; 156(3):283-8. PubMed ID: 21130508
[TBL] [Abstract][Full Text] [Related]
49. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.
Turitto VT; Weiss HJ; Zimmerman TS; Sussman II
Blood; 1985 Apr; 65(4):823-31. PubMed ID: 3872140
[TBL] [Abstract][Full Text] [Related]
50. von Willebrand factor binds to native collagen VI primarily via its A1 domain.
Hoylaerts MF; Yamamoto H; Nuyts K; Vreys I; Deckmyn H; Vermylen J
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):185-91. PubMed ID: 9164855
[TBL] [Abstract][Full Text] [Related]
51. Structure and function of von Willebrand factor.
Hassan MI; Saxena A; Ahmad F
Blood Coagul Fibrinolysis; 2012 Jan; 23(1):11-22. PubMed ID: 22089939
[TBL] [Abstract][Full Text] [Related]
52. In vitro and in vivo evaluation of a factor VIII concentrate heat-treated to inactivate HTLV-III/LAV viruses. Favourable effects of heating on the von Willebrand factor.
Mazurier C; de Romeuf C; Parquet-Gernez A; Jorieux S; Goudemand M
Vox Sang; 1987; 52(4):265-71. PubMed ID: 3114955
[TBL] [Abstract][Full Text] [Related]
53. The Flow Dependent Adhesion of von Willebrand Factor (VWF)-A1 Functionalized Nanoparticles in an in Vitro Coronary Stenosis Model.
Asaad Y; Epshtein M; Yee A; Korin N
Molecules; 2019 Jul; 24(15):. PubMed ID: 31344782
[TBL] [Abstract][Full Text] [Related]
54. Blocking von Willebrand factor free thiols inhibits binding to collagen under high and pathological shear stress.
O'Brien HER; Zhang XF; Sanz-Hernandez M; Chion A; Shapiro S; Mobayen G; Xu Y; De Simone A; Laffan MA; McKinnon TAJ
J Thromb Haemost; 2021 Feb; 19(2):358-369. PubMed ID: 33075181
[TBL] [Abstract][Full Text] [Related]
55. Immunogold labelling of human von Willebrand factor adsorbed to collagen.
Furlan M; Robles R; Lämmle B; Zimmermann J; Hunziker E
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):441-6. PubMed ID: 1932529
[TBL] [Abstract][Full Text] [Related]
56. Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear-induced platelet activation.
Herbig BA; Diamond SL
J Thromb Haemost; 2015 Sep; 13(9):1699-708. PubMed ID: 26178390
[TBL] [Abstract][Full Text] [Related]
57. Differential thrombogenicity of artery and vein: the role of von Willebrand factor.
Cho JS; Ouriel K
Ann Vasc Surg; 1995 Jan; 9(1):60-70. PubMed ID: 7703064
[TBL] [Abstract][Full Text] [Related]
58. Identification of galectin-1 and galectin-3 as novel partners for von Willebrand factor.
Saint-Lu N; Oortwijn BD; Pegon JN; Odouard S; Christophe OD; de Groot PG; Denis CV; Lenting PJ
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):894-901. PubMed ID: 22267483
[TBL] [Abstract][Full Text] [Related]
59. Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions.
Harsfalvi J; Stassen JM; Hoylaerts MF; Van Houtte E; Sawyer RT; Vermylen J; Deckmyn H
Blood; 1995 Feb; 85(3):705-11. PubMed ID: 7833474
[TBL] [Abstract][Full Text] [Related]
60. Coarse-grained simulations of von Willebrand factor adsorption to collagen with consequent platelet recruitment.
Tsyu NG; Belyaev AV
Int J Numer Method Biomed Eng; 2023 Nov; 39(11):e3747. PubMed ID: 37366014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
